Latin America Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Latin America Pharmaceuticals and Healthcare Report

Latin America Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Latin America Pharmaceuticals and Healthcare Report
Published Oct 22, 2016
35 pages — Published Oct 22, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

� Business Monitor International Ltd Page - post a --.- CAGR through to ----. ...The Latin American pharmaceutical market will post a five-year CAGR of -.- in USD terms and -.- CAGR in EUR terms. Government focus on improving industry regulations and increasing access to healthcare services, in addition to a growing chronic disease burden and rising population disease awareness, will continue to be the key driving forces for Latin American pharmaceutical market growth. However, poor reimbursement policies, ongoing intellectual property concerns and drug approval delays will hinder investment returns. Additionally, as a number of economies across the region continue to face headwinds, we are likely to see increasing downward price pressure on medicines as a result of the austerity measures placed on the healthcare sector in the short term.

...As above, growth forecasts are in local currency terms that are aggregated from the country-level US dollar proportions which have been equalized to minimise currency fluctuations using a time series-weighted calculation. ...Indeed, in the long term, as access to healthcare improves, considerable commercial opportunities will be available for drugmakers, medical device companies and healthcare providers. However, in the short term, Latin America s deteriorating political and economic outlook will introduce increasing risks to short-term regional growth prospects for multinational healthcare providers as governments focus on containing spending. The Latin American pharmaceutical market will post a five-year CAGR of -.- in USD terms and -.- CAGR in EUR terms. ...However, in the short term, Latin America s deteriorating political and economic outlook will introduce increasing risks to short-term regional growth prospects for multinational healthcare providers as governments focus on containing spending.

...The region is headed for its second consecutive year of contraction due to subdued commodity prices, weak external demand (notably China, relative to previous growth rates) and tighter external financing conditions. Larger government deficits and tepid growth combined with currency depreciations are contributing to rising government debt. Regional growth projections are influenced by the deep recessions in Brazil and Venezuela, with most other countries growing at a moderate pace. While exchange rate flexibility has helped the region transition to the new external environment, the pass-through from weaker currencies has increased inflationary pressures. Commodity exporters have seen a widening in external imbalances as they are still in the process of absorbing the negative terms-of-trade shock. ...

  
Source:
Document ID
2398-1032
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Latin America Pharmaceuticals and Healthcare Report" Oct 22, 2016. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Latin-America-Pharmaceuticals-and-Healthcare-Report-2026-1990>
  
APA:
Business Monitor International - Industry Reports. (2016). Latin America Pharmaceuticals and Healthcare Report Oct 22, 2016. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Latin-America-Pharmaceuticals-and-Healthcare-Report-2026-1990>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.